By creator to news.google.com
Shares of Baxter Worldwide Inc. (NYSE:BAX – Get Rating) reached a brand new 52-week low throughout buying and selling on Friday after Wells Fargo & Firm lowered their worth goal on the inventory from $59.00 to $57.00. Wells Fargo & Firm presently has an equal weight ranking on the inventory. Baxter Worldwide traded as little as $49.70 and final traded at $49.81, with a quantity of 76326 shares traded. The inventory had beforehand closed at $50.76.
A lot of different equities analysts have additionally issued experiences on BAX. Morgan Stanley decreased their worth goal on shares of Baxter Worldwide from $72.00 to $70.00 and set an “chubby” ranking for the corporate in a analysis report on Tuesday, October 11th. TheStreet lowered shares of Baxter Worldwide from a “c” ranking to a “d+” ranking in a analysis report on Thursday, October 27th. Citigroup lowered shares of Baxter Worldwide from a “purchase” ranking to a “impartial” ranking and decreased their worth goal for the inventory from $64.00 to $58.00 in a analysis report on Monday. Jefferies Monetary Group initiated protection on shares of Baxter Worldwide in a analysis report on Wednesday, October 12th. They set a “maintain” ranking and a $62.00 worth goal for the corporate. Lastly, KeyCorp decreased their worth goal on shares of Baxter Worldwide from $77.00 to $73.00 and set an “chubby” ranking for the corporate in a analysis report on Friday, October 28th. One equities analysis analyst has rated the inventory with a promote ranking, six have issued a maintain ranking and 7 have given a purchase ranking to the corporate’s inventory. Primarily based on information from MarketBeat.com, the inventory presently has a median ranking of “Maintain” and a median goal worth of $68.87.
Institutional Traders Weigh In On Baxter Worldwide
A lot of hedge funds have just lately modified their holdings of the corporate. Quent Capital LLC grew its holdings in shares of Baxter Worldwide by 8.7% within the third quarter. Quent Capital LLC now owns 2,504 shares of the medical devices provider’s inventory valued at $135,00Zero after buying a further 200 shares through the interval. Dorsey & Whitney Belief CO LLC grew its holdings in shares of Baxter Worldwide by 0.6% within the second quarter. Dorsey & Whitney Belief CO LLC now owns 43,404 shares of the medical devices provider’s inventory valued at $2,789,00Zero after buying a further 240 shares through the interval. Shoreline Belief Co boosted its stake in Baxter Worldwide by 0.9% through the second quarter. Shoreline Belief Co now owns 30,731 shares of the medical devices provider’s inventory value $1,973,00Zero after shopping for a further 272 shares through the interval. Quantbot Applied sciences LP boosted its stake in Baxter Worldwide by 1.1% through the third quarter. Quantbot Applied sciences LP now owns 24,656 shares of the medical devices provider’s inventory value $1,327,00Zero after shopping for a further 272 shares through the interval. Lastly, House Federal Financial institution of Tennessee boosted its stake in Baxter Worldwide by 1.7% through the second quarter. House Federal Financial institution of Tennessee now owns 16,155 shares of the medical devices provider’s inventory value $1,038,00Zero after shopping for a further 275 shares through the interval. Hedge funds and different institutional traders personal 84.69% of the corporate’s inventory.
Baxter Worldwide Buying and selling Down 2.3 %
The corporate has a debt-to-equity ratio of two.90, a present ratio of two.11 and a fast ratio of 1.38. The corporate has a market cap of $25.00 billion, a PE ratio of -10.69, a price-to-earnings-growth ratio of two.10 and a beta of 0.59. The corporate’s 50 day easy transferring common is $54.19 and its two-hundred day easy transferring common is $59.50.
Baxter Worldwide (NYSE:BAX – Get Rating) final posted its quarterly earnings information on Thursday, October 27th. The medical devices provider reported $0.82 EPS for the quarter, assembly the consensus estimate of $0.82. Baxter Worldwide had a damaging web margin of 16.12% and a optimistic return on fairness of 22.65%. The enterprise had income of $3.77 billion through the quarter, in comparison with analyst estimates of $3.77 billion. As a gaggle, sell-side analysts anticipate that Baxter Worldwide Inc. will submit 3.57 EPS for the present fiscal 12 months.
Baxter Worldwide Dividend Announcement
The corporate additionally just lately introduced a quarterly dividend, which will likely be paid on Tuesday, January third. Traders of file on Friday, December 2nd will likely be issued a $0.29 dividend. The ex-dividend date is Thursday, December 1st. This represents a $1.16 annualized dividend and a yield of two.34%. Baxter Worldwide’s dividend payout ratio (DPR) is -24.58%.
About Baxter Worldwide
Baxter Worldwide Inc, by its subsidiaries, develops and supplies a portfolio of healthcare merchandise worldwide. The corporate provides peritoneal dialysis and hemodialysis, and extra dialysis therapies and companies; intravenous therapies, infusion pumps, administration units, and drug reconstitution gadgets; remixed and oncology drug platforms, inhaled anesthesia and demanding care merchandise and pharmacy compounding companies; parenteral diet therapies and associated merchandise; organic merchandise and medical gadgets utilized in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and steady renal substitute therapies and different organ assist therapies centered within the intensive care unit.
See Additionally
This immediate information alert was generated by narrative science expertise and monetary information from MarketBeat with a view to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial workforce previous to publication. Please ship any questions or feedback about this story to contact@marketbeat.com.
Earlier than you contemplate Baxter Worldwide, you will wish to hear this.
MarketBeat retains monitor of Wall Road’s top-rated and greatest performing analysis analysts and the shares they advocate to their shoppers each day. MarketBeat has recognized the five stocks that high analysts are quietly whispering to their shoppers to purchase now earlier than the broader market catches on… and Baxter Worldwide wasn’t on the checklist.
Whereas Baxter Worldwide presently has a “Reasonable Purchase” ranking amongst analysts, top-rated analysts consider these 5 shares are higher buys.
— to news.google.com
